Katzenell Dimant represents Mainrom, a public Company traded on TASE in its acquisition (reverse merger) of Kitov Pharmaceuticals Inc. (“Kitov”), in which Kitov’s shareholders sold 100% of their shareholdings in Kitov in exchange for shares of the Company.